C.R. Bard Inc (BCR)

BCR (NYSE:Health Services) EQUITY
$226.16
pos +0.00
+0.00%
Today's Range: 224.96 - 228.64 | BCR Avg Daily Volume: 464,600
Last Update: 06/24/16 - 4:02 PM EDT
Volume: 0
YTD Performance: 19.38%
Open: $0.00
Previous Close: $230.69
52 Week Range: $167.36 - $223.02
Oustanding Shares: 73,318,689
Market Cap: 16,913,888,365
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 2
Moderate Buy 1 1 1 1
Hold 12 12 12 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.67 2.67 2.67 2.67
Latest Dividend: 0.26
Latest Dividend Yield: 0.45%
Dividend Ex-Date: 07/14/16
Price Earnings Ratio: 154.83
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
154.83 162.20 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.11% 31.42% 107.24%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.80 0.10 0.05
Net Income -54.00 -0.70 -0.36
EPS -53.60 -0.70 -0.34
Earnings for BCR:
EBITDA 1.04B
Revenue 3.42B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $2.47 $2.62 $10.14 $11.25
Number of Analysts 12 11 13 14
High Estimate $2.49 $2.68 $10.19 $11.44
Low Estimate $2.45 $2.53 $10.10 $11.12
Prior Year $2.27 $2.28 $9.08 $10.14
Growth Rate (Year over Year) 8.66% 14.87% 11.70% 10.92%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jun 13, 2016 | 7:20 AM EDT

There is so much buying power in so many new areas.

By

Bruce Kamich

 | Jun 6, 2016 | 2:40 PM EDT

Traders should look to go long BCR near $210 if it pulls back.

By

Bruce Kamich

 | Jan 29, 2016 | 11:19 AM EST

Buyers should stay on the sidelines of Bard until a base is formed, potentially at a lower level.

By

Thomas Ward

 | Jan 23, 2016 | 12:00 PM EST

Two significant, but subtle forces may threaten the group in the next 12 months.

By

Bruce Kamich

 | Dec 18, 2015 | 9:11 AM EST

We would begin trimming our position with a stop-loss just below $180.

By

Bruce Kamich

 | Oct 5, 2015 | 12:30 PM EDT

With no top in sight, we remain bulls on this name.

By

Jim Cramer

 | Sep 1, 2015 | 12:14 PM EDT

Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), and Boston Scientific (BSX).

updateCR Bard rated new Sector Weight at Keybanc

Aug 27, 2015 | 6:51 AM EDT

Coverage of BCR was started with a Sector Weight rating, Keybanc said. Stock is already pricing in a better sales outlook. 

By

Dick Arms

 | Aug 13, 2015 | 7:00 AM EDT

The last two days have changed the entire structure of the markets.

By

Jim Cramer

 | Aug 10, 2015 | 5:40 AM EDT

There are some good buying ideas among these stocks.

Market alarmists say the United Kingdom will be doomed because of the pounding that the Br...
As of 7:11 PM, the DJIA and S&P 500 futures indicated perhaps 0.5% to 0.6% downside on...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.